A Survey of Senior Chemical Industry ExecutivesJonathan Choi2026-08-06T22:24:53+00:00August 1st, 2026|Featured, Our Publications|
Chemical M&A Surges (ICIS Chemical Business July 31, 2026)Jonathan Choi2026-08-06T22:27:14+00:00July 31st, 2026|Featured, Our Publications|
Cautious Momentum: Biopharma Review and Outlook (Pharmaceutical Executive March 2026)Jonathan Choi2026-03-26T17:22:07+00:00March 26th, 2026|Featured, Our Publications|
Chemicals M&A To See Upturn in 2026 (Chemical Week Feb 2 – Feb 9, 2026)Jonathan Choi2026-02-23T22:49:38+00:00February 23rd, 2026|Featured, Our Publications|
The Good, The Bad, and the Ugly (ICIS Chemical Business Jan 30 – Feb 5, 2026)Jonathan Choi2026-02-18T14:30:15+00:00February 18th, 2026|Featured, Our Publications|
Signs of Revival in Chemical M&A (ICIS Chemical Business Jan 23 – Jan 29, 2026)Jonathan Choi2026-02-18T14:28:50+00:00February 18th, 2026|Featured, Our Publications|
Pharmaceutical Executive Academy: The Impact of AI on the Life Science Industry with Najat KhanJonathan Choi2026-02-12T22:45:09+00:00February 12th, 2026|Our Broadcasts|
Financing Markets Mixed, Equities Lag (ICIS Chemical Business Nov 27 – Dec 4, 2025)Jonathan Choi2025-12-19T16:33:57+00:00December 4th, 2025|Featured, Our Publications|
Chemical M&A Mixed, Sideways (ICIS Chemical Business Nov 21 – Nov 27, 2025)Jonathan Choi2025-12-19T16:21:22+00:00November 27th, 2025|Featured, Our Publications|
Young & Partners 2025 Pharmaceutical Executive Summit: Will China Overtake the West in Drug Development?Jonathan Choi2025-12-18T23:22:14+00:00November 12th, 2025|Our Broadcasts|
